Compare ATOM & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATOM | NAUT |
|---|---|---|
| Founded | 2001 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.6M | 383.5M |
| IPO Year | 2016 | 2020 |
| Metric | ATOM | NAUT |
|---|---|---|
| Price | $8.94 | $2.93 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 3.0M | 280.6K |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 4.41 | ★ 16.07 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $62,000.00 | N/A |
| Revenue This Year | $527.69 | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | $0.62 |
| 52 Week High | $11.48 | $4.31 |
| Indicator | ATOM | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 61.49 | 52.50 |
| Support Level | $2.65 | $2.83 |
| Resistance Level | N/A | $3.18 |
| Average True Range (ATR) | 1.44 | 0.23 |
| MACD | 0.32 | 0.01 |
| Stochastic Oscillator | 60.42 | 66.23 |
Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used in the semiconductor industry. The company's silicon technology can be used for applications like Analog, DRAM, logic, processors, and SRAM. Geographically, it generates maximum revenue from North America.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.